GENE ONLINE|News &
Opinion
Blog

Oncology
Merger Announced Between Immunome and Morphimmune
2023-07-05
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
GeneOnline’s Weekly News Highlights: June 19-23
2023-06-26
Pyramid Biosciences Bets $1B on Oncology Drug
2023-04-17
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
FDA Drops New Oncology Development Guidelines
2022-10-18
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
1 2 3 6
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top